Contents
Aflavic is used to treat symptoms associated with venous insufficiency in the lower extremities, such as a feeling of heaviness in the legs, leg pain and ailments associated with haemorrhoids. Treatment with the preparation should be symptomatic and short-term.
Aflavic (Polfarmex)
form, dose, packaging | availability category | the active substance |
tabl. powl. 0,6 g (30 tabl.) | OTC (over-the-counter) | diosmina (diosmin) |
ACTION
A flavonoid that has a protective effect on venous vessels
Aflavic – indications and dosage
Aflavic is a preparation that strengthens capillaries. It is used as:
- treatment of symptoms associated with venous insufficiency of the lower extremities, such as a feeling of heaviness in the legs, leg pain. Orally. 1 tablet / day, in the morning, on an empty stomach,
- symptomatic treatment of exacerbation of ailments related to haemorrhoids. Orally. 2-3 tablets / day during meals.
Aflavic and contraindications
A contraindication to the use of Aflavic is hypersensitivity to any of its ingredients.
Aflavic – warnings
- It should be remembered that treatment with Aflavic is only symptomatic and should be short-term.
- If during the treatment the symptoms related to haemorrhoids do not disappear or worsen, a proctological examination is recommended.
- People with hereditary disorders of galactose intolerance, lactase deficiency or malabsorption of glucose-galactose should not use the preparation.
- There are no data on the safety of use of Aflavic in pregnant and breastfeeding women. The preparation can be used in pregnant women only after consulting a doctor and only if absolutely necessary.
- It is recommended to avoid breastfeeding while taking the preparation.
- There are no studies on the effect of the preparation on the ability to drive motor vehicles.
Aflavic – interactions
There are no known interactions of Aflavic with other drugs.
Aflavic – side effects
While taking Aflavic, the following may occur: diarrhea, indigestion, nausea, vomiting, dizziness and headache, malaise, rash, itching, hives. Treatment discontinuation is not required in the case of mild gastrointestinal side effects and neurovegetative disorders.